242 related articles for article (PubMed ID: 18786169)
1. Up-regulation of the SOX3 gene expression by retinoic acid: characterization of the novel promoter-response element and the retinoid receptors involved.
Nikcević G; Savić T; Kovacević-Grujicić N; Stevanović M
J Neurochem; 2008 Dec; 107(5):1206-15. PubMed ID: 18786169
[TBL] [Abstract][Full Text] [Related]
2. PBX1 and MEIS1 up-regulate SOX3 gene expression by direct interaction with a consensus binding site within the basal promoter region.
Mojsin M; Stevanovic M
Biochem J; 2009 Dec; 425(1):107-16. PubMed ID: 19799567
[TBL] [Abstract][Full Text] [Related]
3. Mapping of the RXRalpha binding elements involved in retinoic acid induced transcriptional activation of the human SOX3 gene.
Mojsin M; Grujicić NK; Nikcević G; Krstić A; Savić T; Stevanović M
Neurosci Res; 2006 Dec; 56(4):409-18. PubMed ID: 17005281
[TBL] [Abstract][Full Text] [Related]
4. Functional characterization of the human SOX3 promoter: identification of transcription factors implicated in basal promoter activity.
Kovacevic Grujicic N; Mojsin M; Krstic A; Stevanovic M
Gene; 2005 Jan; 344():287-97. PubMed ID: 15656994
[TBL] [Abstract][Full Text] [Related]
5. Retinoic acid upregulates cone arrestin expression in retinoblastoma cells through a Cis element in the distal promoter region.
Li A; Zhu X; Craft CM
Invest Ophthalmol Vis Sci; 2002 May; 43(5):1375-83. PubMed ID: 11980849
[TBL] [Abstract][Full Text] [Related]
6. Regulation of SOX3 gene expression is driven by multiple NF-Y binding elements.
Krstic A; Mojsin M; Stevanovic M
Arch Biochem Biophys; 2007 Nov; 467(2):163-73. PubMed ID: 17910945
[TBL] [Abstract][Full Text] [Related]
7. TG-interacting factor (TGIF) downregulates SOX3 gene expression in the NT2/D1 cell line.
Mojsin M; Popovic J; Kovacevic Grujicic N; Stevanovic M
J Genet Genomics; 2012 Jan; 39(1):19-27. PubMed ID: 22293114
[TBL] [Abstract][Full Text] [Related]
8. Specific retinoid receptors cooperate to signal growth suppression and maturation of human embryonal carcinoma cells.
Spinella MJ; Kitareewan S; Mellado B; Sekula D; Khoo KS; Dmitrovsky E
Oncogene; 1998 Jul; 16(26):3471-80. PubMed ID: 9692555
[TBL] [Abstract][Full Text] [Related]
9. Derivation and characterization of retinoid-resistant human embryonal carcinoma cells.
Moasser MM; Khoo KS; Maerz WJ; Zelenetz A; Dmitrovsky E
Differentiation; 1996 Jul; 60(4):251-7. PubMed ID: 8765055
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the human MSX-1 promoter and an enhancer responsible for retinoic acid induction.
Shen R; Chen Y; Huang L; Vitale E; Solursh M
Cell Mol Biol Res; 1994; 40(4):297-312. PubMed ID: 7866431
[TBL] [Abstract][Full Text] [Related]
11. Identification and characterization of the human retinoid X receptor alpha gene promoter.
Li G; Yin W; Chamberlain R; Hewett-Emmett D; Roberts JN; Yang X; Lippman SM; Clifford JL
Gene; 2006 May; 372():118-27. PubMed ID: 16517099
[TBL] [Abstract][Full Text] [Related]
12. Retinoids directly activate the collagen X promoter in prehypertrophic chondrocytes through a distal retinoic acid response element.
Cohen AJ; Lassová L; Golden EB; Niu Z; Adams SL
J Cell Biochem; 2006 Sep; 99(1):269-78. PubMed ID: 16598786
[TBL] [Abstract][Full Text] [Related]
13. SREBP-1c mediates the retinoid-dependent increase in fatty acid synthase promoter activity in HepG2.
Roder K; Zhang L; Schweizer M
FEBS Lett; 2007 Jun; 581(14):2715-20. PubMed ID: 17531980
[TBL] [Abstract][Full Text] [Related]
14. Utilization of DR1 as true RARE in regulating the Ssm, a novel retinoic acid-target gene in the mouse testis.
Han K; Song H; Moon I; Augustin R; Moley K; Rogers M; Lim H
J Endocrinol; 2007 Mar; 192(3):539-51. PubMed ID: 17332523
[TBL] [Abstract][Full Text] [Related]
15. Genomic organization and promoter analysis of mouse disabled 2 gene.
Cho SY; Park SS
Biochem Biophys Res Commun; 2000 Aug; 275(1):189-94. PubMed ID: 10944463
[TBL] [Abstract][Full Text] [Related]
16. The promoter context is a decisive factor in establishing selective responsiveness to nuclear class II receptors.
Sanguedolce MV; Leblanc BP; Betz JL; Stunnenberg HG
EMBO J; 1997 May; 16(10):2861-73. PubMed ID: 9184230
[TBL] [Abstract][Full Text] [Related]
17. The human semaphorin 6B gene is down regulated by PPARs.
Collet P; Domenjoud L; Devignes MD; Murad H; Schohn H; Dauça M
Genomics; 2004 Jun; 83(6):1141-50. PubMed ID: 15177567
[TBL] [Abstract][Full Text] [Related]
18. Suppression of mammary carcinoma cell growth by retinoic acid: the cell cycle control gene Btg2 is a direct target for retinoic acid receptor signaling.
Donato LJ; Suh JH; Noy N
Cancer Res; 2007 Jan; 67(2):609-15. PubMed ID: 17234770
[TBL] [Abstract][Full Text] [Related]
19. FGF4 dissociates anti-tumorigenic from differentiation signals of retinoic acid in human embryonal carcinomas.
Maerz WJ; Baselga J; Reuter VE; Mellado B; Myers ML; Bosl GJ; Spinella MJ; Dmitrovsky E
Oncogene; 1998 Aug; 17(6):761-7. PubMed ID: 9715278
[TBL] [Abstract][Full Text] [Related]
20. Agonist and antagonist of retinoic acid receptors cause similar changes in gene expression and induce senescence-like growth arrest in MCF-7 breast carcinoma cells.
Chen Y; Dokmanovic M; Stein WD; Ardecky RJ; Roninson IB
Cancer Res; 2006 Sep; 66(17):8749-61. PubMed ID: 16951191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
